Insider trades › Amgen › Nancy A. Grygiel

Nancy A. Grygiel: Amgen stock transactions

Nancy A. Grygiel (SVP & CCO at Amgen) reported 4 transactions in AMGN stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Grygiel Nancy A..

$1.2Mopen-market sales (2,970 shares)
$0open-market purchases (0 shares)
2026-08-06most recent transaction

Transactions

Date Transaction Shares Price Value Filing
Aug 6, 2026 Option or RSU exercise 1,970 $177.46 — Form 4 ↗
Aug 6, 2026 Open-market sale 1,970 $402.16 $792K Form 4 ↗
Aug 6, 2026 Option or RSU exercise 1,000 $177.31 — Form 4 ↗
Aug 6, 2026 Open-market sale 1,000 $402.16 $402K Form 4 ↗

Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.